Dr. Webster recaps his AAD 2022 presentation, which explored topics in acne, such as the myth of “maskne,” isotretinoin-resistant acne lesions, and instances of muscle damage in patients taking isotretinoin.
Dr. Taylor discusses the gaps in dermatology education regarding skin of color and introduces the
Dr. Harris provides an overview of the most exciting topics he discussed during his several
Dr. Ständer reviews her AAD 2022 presentation, which focused on prurigo nodularis; she discusses impacts
Dr. Lio reviews his AAD presentation, which focused on disentangling the mythology around nutrition and
Dr. Elbuluk discusses her AAD 2022 presentation, which touched on topics such as post-inflammatory hyperpigmentation
Dr. Sidbury directed the AAD 2022 session, “Translating Evidence into Practice: Atopic Dermatitis Guidelines.” Here,
Dr. Barbieri recaps his presentation from the acne symposium at AAD 2022, in which he
Dr. Keaney reviews his AAD 2022 presentation in which he provided guidance for optimizing PRP
Dr. Chovatiya discusses his research that he presented at AAD 2022, which examined out-of-pocket costs
Dr. Stein Gold provides an overview of her lectures from AAD 2022, which explored new
Dr. Harper discusses her AAD 2022 presentation on acne advocacy, which entails not only advocating
Dr. Desai discusses his AAD 2022 presentation, which focused on a variety of new non-hydroquinone
Dr. Tosti reviews the useful and accessible technique of dermoscopy, which she asserts every dermatologist
Dr. Grimes, Chair of the AAD 2022 session, “Where Do We Stand? The Pathogenesis and
Dr. Prussick discusses the importance of recognizing and addressing the most common comorbidities in patients
Dr. Bhatia reviews his AAD 2022 presentation on wise antibiotic use in dermatology.
Dr. Desai discusses his AAD 2022 presentation, which focused on a variety of new non-hydroquinone
JCAD’s coverage of the 2022 AAD Annual Meeting is not endorsed by or affiliated with the American Academy of Dermatology (AAD).
